Parametric Portfolio Associates LLC raised its holdings in shares of Clorox Co (NYSE:CLX) by 3.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 536,640 shares of the company’s stock after buying an additional 20,303 shares during the quarter. Parametric Portfolio Associates LLC owned about 0.42% of Clorox worth $70,788,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of CLX. Vanguard Group Inc. raised its stake in shares of Clorox by 2.6% in the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after purchasing an additional 369,918 shares in the last quarter. Parnassus Investments CA raised its stake in shares of Clorox by 1.7% in the third quarter. Parnassus Investments CA now owns 4,451,150 shares of the company’s stock valued at $587,151,000 after purchasing an additional 76,236 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Clorox by 5.3% in the second quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after purchasing an additional 221,168 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of Clorox by 24.5% in the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock valued at $178,728,000 after purchasing an additional 263,700 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of Clorox by 24.6% in the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after purchasing an additional 265,200 shares in the last quarter. Institutional investors own 73.42% of the company’s stock.
Clorox Co (NYSE:CLX) opened at $147.63 on Monday. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10. Clorox Co has a 12 month low of $117.94 and a 12 month high of $148.23. The stock has a market capitalization of $19,037.84, a price-to-earnings ratio of 26.60, a price-to-earnings-growth ratio of 4.02 and a beta of 0.43.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a yield of 2.28%. Clorox’s dividend payout ratio is currently 61.88%.
A number of research analysts recently commented on CLX shares. BMO Capital Markets restated a “buy” rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, October 5th. Morgan Stanley cut their target price on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a research note on Thursday, November 2nd. Jefferies Group restated a “hold” rating and issued a $132.00 target price on shares of Clorox in a research note on Wednesday, November 1st. Royal Bank of Canada restated a “hold” rating and issued a $115.00 target price on shares of Clorox in a research note on Sunday, October 8th. Finally, Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $129.05.
In other news, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the sale, the senior vice president now owns 34,867 shares in the company, valued at $4,742,260.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the sale, the senior vice president now owns 10,896 shares in the company, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Clorox Co (CLX) Shares Bought by Parametric Portfolio Associates LLC” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.com-unik.info/2017/12/18/clorox-co-clx-shares-bought-by-parametric-portfolio-associates-llc.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.